FibroBiologics, Inc. (FBLG) Free cash flow 2023–2025
FibroBiologics, Inc. (FBLG) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.7MFY2025 · since FY2023: -$6.9M → -$16.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.7M | -37.8% |
| FY2024 | -$12.1M | -75.2% |
| FY2023 | -$6.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More FBLG financial trends
FBLG RevenueFBLG Net incomeFBLG Net marginFBLG Gross profitFBLG Gross marginFBLG Operating incomeFBLG Operating marginFBLG Operating cash flowFBLG Capital expendituresFBLG Return on equityFBLG Stock buybacksFBLG Dividends paidFBLG Total assetsFBLG Total liabilitiesFBLG Shareholders’ equityFBLG overview →